Bangi Inc (BNGI)

[surfkast]

Describe the Issuer’s Business, Products and Services
A. A description of the Issuer’s business operations: Compass is structured as a biotechnology research and
development, company, focusing on the development and commercialization of generic, bio-similar and bio-better
drug products.
B. Date and State (or Jurisdiction) of Incorporation: The company was incorporated under the laws of the
State of Nevada on May 12th, 2004.
C. The Issuer’s primary and secondary SIC Codes; Primary SIC Code: 2834 Secondary SIC Code: None
D. The Issuer’s fiscal year end date; January 31
E. Principal products and services and their markets; Compass is structured as a biotechnology research and
development, company, focusing on the development and commercialization of generic, bio-similar and bio-better
drug products.
7) Describe the Issuer’s Facilities
The Company’s current CEO provides office space free of charge at 8904-60th Avenue, Edmonton, Alberta, Canada,
T6E 6A6. The Company is currently in the process of relocating its operations and expects to secure office space
shortly.

COBI — Quarterly Report

Published: Nov 07, 2016 Period End: Jul 31, 2016